-
The raloxifene use for the heart (RUTH) trial was an international randomized, placebo-controlled trial that enrolled 10,101 postmenopausal women in two groups, one at high risk for coronary heart disease, and one with established coronary heart disease.
-
A large prospective randomized trial (n = 2812 women) was retrospectively analyzed to look at contraceptive efficacy and weight/BMI.
-
-
In this issue: Comparing blood pressure medications, determining optimal length of androgen-deprivation therapy, red yeast rice for LDL reduction, and FDA Actions.
-
About 30 years ago (so long ago that I can't remember the exact year), I began to edit a monthly newsletter devoted to reproductive medicine.
-
Preclinical data recently demonstrated the extreme sensitivity of BRCA-deficient cells to inhibition of the single-strand repair enzyme poly(ADP-ribose) polymerase (PARP).
-
-
What is included in your practice during a first prenatal visit? If syphilis screening is not on the list, be sure to add it. Following a systematic review of current evidence, the U.S. Preventive Services Task Force has just reaffirmed its 2004 recommendation that clinicians screen all pregnant women for syphilis infection.
-
Wondering how to get prevention messages to adolescents? Public health officials are looking at new approaches such as text messaging on cell phones and Internet social networking sites to reach, educate, and engage teens regarding their sexual and reproductive health.
-
Look out in the waiting room of your clinic. How many patients are waiting to be seen by a provider to be tested for a sexually transmitted infection (STI)?